Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2023-01-07 21:26:51]
5 Years H Index
6
Impact Factor (IF)
0.08
5 Years IF
0.07
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
2012 0 0.51 0 0 7 7 0 0 0 0 0 0 0.22
2014 0 0.55 0 0 8 15 10 0 7 7 0 0 0.23
2015 0 0.55 0 0 1 16 0 0 8 15 0 0 0.23
2016 0.22 0.53 0.11 0.13 98 114 73 12 12 9 2 16 2 11 91.7 10 0.1 0.21
2017 0.15 0.55 0.15 0.16 119 233 74 34 46 99 15 114 18 30 88.2 11 0.09 0.21
2018 0.14 0.57 0.16 0.14 134 367 67 59 105 217 30 226 31 51 86.4 21 0.16 0.24
2019 0.09 0.6 0.15 0.07 131 498 53 76 181 253 22 360 26 68 89.5 33 0.25 0.24
2020 0.11 0.73 0.12 0.09 130 628 33 73 254 265 29 483 44 51 69.9 10 0.08 0.34
2021 0.08 1.02 0.1 0.07 124 752 17 78 332 261 22 612 45 48 61.5 9 0.07 0.38
IF: Two years Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for all series in RePEc in year y
CIF: Cumulative impact factor
IF5: Five years Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12017Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Starren, Justin ; Carson, Matthew B ; Jonnalagadda, Siddhartha R ; Berendsen, Mark A ; Zeng, Zexian ; Herr, Timothy M ; Thompson, William K ; Luo, Yuan. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6.

Full description at Econpapers || Download paper

7
22018Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E ; Watson, Sarah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2.

Full description at Econpapers || Download paper

7
32014Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave ; LePendu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David ; Callahan, Alison ; Low, Yen . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790.

Full description at Econpapers || Download paper

7
42017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled ; Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

7
52017Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Fransson, Jonas ; Noren, Niklas G ; Chandler, Rebecca E ; Juhlin, Kristina ; Edwards, Ralph I ; Caster, Ola. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3.

Full description at Econpapers || Download paper

6
62016Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

6
72019Patient Registries: An Underused Resource for Medicines Evaluation. (2019). PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel Nogueras ; Castillon, Mireia ; Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00848-9.

Full description at Econpapers || Download paper

5
82016The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Puijenbroek, Eugene ; Taxis, Katja ; Hunsel, Florence ; Rolfes, Lean. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0.

Full description at Econpapers || Download paper

5
92016Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. (2016). Ryan, Cristin ; Hughes, Carmel M ; Cadogan, Cathal A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0378-5.

Full description at Econpapers || Download paper

5
102016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen ; Sarker, Abeed . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

5
112019Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding. (2019). Kong, Xiangnan ; Rundensteiner, Elke A ; Sen, Cansu ; Kakar, Tabassum ; Qin, Xiao ; Wunnava, Susmitha. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0765-9.

Full description at Econpapers || Download paper

4
122017Patient Reporting in the EU: Analysis of EudraVigilance Data. (2017). Arlett, Peter ; Genov, Georgy ; Haerry, David ; Houez, Francois ; Slattery, Jim ; Candore, Gianmario ; Banovac, Marin . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0534-1.

Full description at Econpapers || Download paper

4
132016Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Thomas, Michele ; Burstein, Phil J ; Powell, Gregory E ; Brownstein, John S ; Painter, Jeffery L ; Dasgupta, Nabarun ; Rodriguez, Harold W ; Pierce, Carrie E ; Bell, Heidi G ; Menius, Alan J ; Freifeld, Clark C ; Blowers, James ; Reblin, Tjark ; Seifert, Harry A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6.

Full description at Econpapers || Download paper<

4
142016The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Smith, Meredith Y ; Benattia, Isma . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9.

Full description at Econpapers || Download paper

4
152019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Vries, Sieta T ; Antoni, ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download Detecting Adverse Drug Events with Rapidly Trained Classification Models. (2019). Patterson, Olga V ; Duvall, Scott L ; Alba, Patrick R ; Peterson, Kelly S ; Chapman, Alec B. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0763-y.

Full description at Econpapers || Download paper

4
172016Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database. (2016). Pratt, Nicole L ; Roughead, Elizabeth E ; Ellett, Lisa Kalisch ; Wahab, Izyan A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0391-8.

Full description at Econpapers || Download paper

4
182018Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Moore, Nicholas ; Blin, Patrick ; Droz, Cecile ; Lassalle, Regis ; Abouelfath, Abdelilah ; Duong, Mai. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7.

Full description at Econpapers || Download paper

4
192018Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. (2018). Fine, Jennifer ; Ramakrishnan, Cartic ; Nagarajan, Meenakshi ; Meireis, Shawman ; Dorrell, Darren ; Hudson, Zoe ; Perera, Sujan ; Comfort, Shaun. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0641-7.

Full description at Econpapers || Download paper

4
202016Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities’ Views and Needs. (2016). Matos, Cristiano ; Hunsel, Florence ; Harmark, Linda. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6.

Full description at Econpapers || Download paper

4
212019MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes. (2019). Wu, Yonghui ; Hogan, William R ; Gong, Yan ; Bian, Jiang ; Yang, XI. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0761-0.

Full description at Econpapers || Download paper

4
222018From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. (2018). Bate, Andrew ; Sultana, Janet ; Trifiro, Gianluca. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4.

Full description at Econpapers || Download paper

3
232019Artificial Intelligence and the Future of the Drug Safety Professional. (2019). Widdowson, Mark ; Abatemarco, Danielle ; Mockute, Ruta ; Tetarenko, Niki ; Assuncao, Bruno ; Mingle, Edward ; Cicirello, Salvatore ; Danysz, Karolina ; Desai, Sameen. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0746-z.

Full description at Econpapers || Download paper

3
242019Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance. (2019). Dal, Gerald J ; Wu, Eileen ; Muoz, Monica A ; Kortepeter, Cindy M ; Kalra, Dipti ; Harinstein, Lisa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-0759-7.

Full description at Econpapers || Download paper

3
252020Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Bowling, Rich ; Popko, Leszek ; Barmaz, Yves ; Rolo, Donato ; Koneswarakantha, Bjorn ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3.

Full description at Econpapers || Download paper

3
262016Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. (2016). Olsson, Sten ; Pal, Shanthi N ; Hoekman, Jarno ; Alexander, ; Bruin, Marieke L ; Ampadu, Haggar H ; Sartori, Daniele. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0387-4.

Full description at Econpapers || Download paper

3
272016National ADR Monitoring System in China. (2016). Ye, Xiaofei ; Hou, Yongfang ; Li, Xinling ; Wu, Guizhi . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0446-5.

Full description at Econpapers || Download paper

3
282017Causality Assessment in Pharmacovigilance: Still a Challenge. (2017). Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0509-2.

Full description at Econpapers || Download paper

3
292020Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical. (2020). de Climens, Aude Roborel ; Nguyen-Pascal, My-Lien ; Burrows, Kate ; Brun-Strang, Catherine ; Findley, Amy ; Reaney, Matthew ; Gater, Adam. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:2:d:10.1007_s40264-019-00877-4.

Full description at Econpapers || Download

3
302016Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports. (2016). Puijenbroek, Eugene P ; Broekmans, Andre W ; Stolk, Pieter ; Bruin, Marie L ; Vermeer, Niels S ; Klein, Kevin. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0383-8.

Full description at Econpapers || Download paper

3
312017An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. (2017). Singh, Sonal ; Segal, Jodi B ; Marimuthu, Sathiya Priya ; Iyer, Geetha . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:9:d:10.1007_s40264-017-0550-1.

Full description at Econpapers || Download paper

3
322020Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. (2020). Keers, Richard N ; Steinke, Douglas ; Alqenae, Fatema A. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:6:d:10.1007_s40264-020-00918-3.

Full description at Econpapers || Download paper

3
332018Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. (2018). Pers, Yves-Marie ; Jorgensen, Christian ; Vernhet, Helene ; Roubille, Franois ; Chatre, Clotilde. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0689-4.

Full description at Econpapers || Download paper

3
342018Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. (2018). Vroman, Benoit ; Tcherny-Lessenot, Stephanie ; Noren, Niklas G ; Maskell, Simon ; Lerch, Magnus ; Kurzinger, Marie-Laure ; Dietrich, Juergen ; Caster, Ola ; Stekelenborg, John ; Wisniewski, Antoni. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0699-2.

Full description at Econpapers || Download The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. (2019). Mugelli, Alessandro ; Clavenna, Antonio ; Corrao, Giovanni ; Moretti, Ugo ; Carnovale, Carla ; Mantovani, Lorenzo ; Lucenteforte, Ersilia ; Capuano, Annalisa ; Vannacci, Alfredo ; Leoni, Olivia ; Cantarutti, Anna ; Traversa, Giuseppe ; Leone, Roberto ; Beghi, Ettore ; Tettamanti, Mauro ; Lapi, Francesco ; Barone-Adesi, Francesco ; Sultana, Janet ; Kirchmayer, Ursula ; Gini, Rosa ; Rea, Federico ; Ingrasciotta, Ylenia ; Trifiro, Gianluca ; Rafaniello, Concita ; Franchi, Matteo ; Poluzzi, Elisabetta ; Ferrajolo, Carmen ; Naldi, Luigi ; Dellagiovanna, Mirosa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-07

3
362017Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences. (2017). Andri, Adriana ; Ipi, Ivana ; Montero, Dolores ; Coleman, Anna Marie ; Baldelli, Ilaria ; Cupelli, Amelia ; PEter, ; Vries, Sieta T ; Denig, Petra ; Ahlqvist-Rastad, Jane ; Wennberg, Annika . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0535-0.

Full description at Econpapers || Download paper

3
372016Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention. (2016). Newbould, Victoria ; Goedecke, Thomas ; Ord, Kathryn ; Arlett, Peter ; Brosch, Sabine. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0410-4.

Full description at Econpapers || Download paper

3
382016Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. (2016). Curtain, Colin M ; Angamo, Mulugeta Tarekegn ; Ke, LU ; Chalmers, Leanne. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0444-7.

Full description at Econpapers || Download paper

3
392017Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals. (2017). Bereznicki, Luke R ; Connolly, Michael ; Peterson, Gregory M ; Curtain, Colin ; Chalmers, Leanne ; Nair, Nibu Parameswaran . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0528-z.

Full description at Econpapers || Download paper

3
402019Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Yu, Hong ; Liu, Weisong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z.

Full description at Econpapers || Download paper

3
412019Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning. (2019). Popko, Leszek ; Bowling, Rich ; Koneswarakantha, Bjorn ; Barmaz, Yves ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00831-4.

Full description at Econpapers || Download paper

3
422019The Role of European Patient Organizations in Pharmacovigilance. (2019). Hunsel, Florence ; Weits, Gerda ; Matos, Cristiano. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0748-x.

Full description at Econpapers || Download paper

3
432017Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature. (2017). Bouder, Frederic ; Way, Dominic ; Blazsin, Hortense ; Lofstedt, Ragnar. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0466-1.

Full description at Econpapers || Download paper

3
442017Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. (2017). , Peter ; PEter, ; Ruiz, Carmen Lasheras ; Houez, Franois ; Sutcliffe, Alastair ; Wong, Lisa ; Vries, Sieta T. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-016-0494-x.

Full description at Econpapers || Download paper

3
452016Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. (2016). Arani, Ramin ; Wisniewski, Antoni ; Quarcoo, Naashika ; Juhlin, Kristina ; Candore, Gianmario ; Seabroke, Suzie ; Tregunno, Philip ; Painter, Jeffery ; Slattery, Jim ; Noren, Niklas G. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0388-3.

Full description at Econpapers || Download paper

3
462016Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records. (2016). Vilar, Santiago ; Banda, Juan M ; Callahan, Alison ; Winnenburg, Rainer ; Reis, Ben Y ; Cami, Aurel ; Strasberg, Howard R ; Hripcsak, George ; Dumontier, Michel ; Shah, Nigam Haresh . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0352-2.

Full description at Econpapers || Download paper

2
472017Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works. (2017). Arlett, Peter ; Raine, June ; Spooner, Almath ; Genov, Georgy ; Santoro, Aniello. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:10:d:10.1007_s40264-017-0572-8.

Full description at Econpapers || Download paper

2
482018Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. (2018). Dasgupta, Nabarun ; Wolfe, Daniel ; Saucier, Roxanne. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0653-3.

Full description at Econpapers || Download paper

2
492019Correction to: A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding. (2019). Frauman, Albert ; Aminian, Parnaz ; Keith, Claire ; Liew, David ; McMaster, Christopher. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-019-00820-7.

Full description at Econpapers || Download paper

2
502014Pharmacovigilance in China: Current Situation, Successes and Challenges. (2014). He, Ying ; Zhang, LI ; Wong, Lisa . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:765-770.

Full description at Econpapers || Download paper

2
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12017Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Starren, Justin ; Carson, Matthew B ; Jonnalagadda, Siddhartha R ; Berendsen, Mark A ; Zeng, Zexian ; Herr, Timothy M ; Thompson, William K ; Luo, Yuan. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6.

Full description at Econpapers || Download paper

5
22017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled ; Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

5
32018Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. (2018). Fine, Jennifer ; Ramakrishnan, Cartic ; Nagarajan, Meenakshi ; Meireis, Shawman ; Dorrell, Darren ; Hudson, Zoe ; Perera, Sujan ; Comfort, Shaun. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0641-7.

Full description at Econpapers || Download paper

4
42018Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E ; Watson, Sarah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2.

Full description at Econpapers || Download paper

4
52020Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. (2020). Keers, Richard N ; Steinke, Douglas ; Alqenae, Fatema A. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:6:d:10.1007_s40264-020-00918-3.

Full description at Econpapers || Download paper

3
62019Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning. (2019). Popko, Leszek ; Bowling, Rich ; Koneswarakantha, Bjorn ; Barmaz, Yves ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00831-4.

Full description at Econpapers || Download paper

3
72019The Role of European Patient Organizations in Pharmacovigilance. (2019). Hunsel, Florence ; Weits, Gerda ; Matos, Cristiano. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0748-x.

Full description at Econpapers || Download paper

3
82019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Vries, Sieta T ; Antoni, ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical. (2020). de Climens, Aude Roborel ; Nguyen-Pascal, My-Lien ; Burrows, Kate ; Brun-Strang, Catherine ; Findley, Amy ; Reaney, Matthew ; Gater, Adam. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:2:d:10.1007_s40264-019-00877-4.

Full description at Econpapers || Download

3
102019Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding. (2019). Kong, Xiangnan ; Rundensteiner, Elke A ; Sen, Cansu ; Kakar, Tabassum ; Qin, Xiao ; Wunnava, Susmitha. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0765-9.

Full description at Econpapers || Download paper

3
112016Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. (2016). Ryan, Cristin ; Hughes, Carmel M ; Cadogan, Cathal A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0378-5.

Full description at Econpapers || Download paper

3
122016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen ; Sarker, Abeed . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

3
132017Patient Reporting in the EU: Analysis of EudraVigilance Data. (2017). Arlett, Peter ; Genov, Georgy ; Haerry, David ; Houez, Francois ; Slattery, Jim ; Candore, Gianmario ; Banovac, Marin . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0534-1.

Full description at Econpapers || Download paper

3
142018Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. (2018). Pers, Yves-Marie ; Jorgensen, Christian ; Vernhet, Helene ; Roubille, Franois ; Chatre, Clotilde. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0689-4.

Full description at Econpapers || Download paper

3
152019The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. (2019). Mugelli, Alessandro ; Clavenna, Antonio ; Corrao, Giovanni ; Moretti, Ugo ; Carnovale, Carla ; Mantovani, Lorenzo ; Lucenteforte, Ersilia ; Capuano, Annalisa ; Vannacci, Alfredo ; Leoni, Olivia ; Cantarutti, Anna ; Traversa, Giuseppe ; Leone, Roberto ; Beghi, Ettore ; Tettamanti, Mauro ; Lapi, Francesco ; Barone-Adesi, Francesco ; Sultana, Janet ; Kirchmayer, Ursula ; Gini, Rosa ; Rea, Federico ; Ingrasciotta, Ylenia ; Trifiro, Gianluca ; Rafaniello, Concita ; Franchi, Matteo ; Poluzzi, Elisabetta ; Ferrajolo, Carmen ; Naldi, Luigi ; Dellagiovanna, Mirosa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-073
162017Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature. (2017). Bouder, Frederic ; Way, Dominic ; Blazsin, Hortense ; Lofstedt, Ragnar. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0466-1.

Full description at Econpapers || Download paper

3
172019Artificial Intelligence and the Future of the Drug Safety Professional. (2019). Widdowson, Mark ; Abatemarco, Danielle ; Mockute, Ruta ; Tetarenko, Niki ; Assuncao, Bruno ; Mingle, Edward ; Cicirello, Salvatore ; Danysz, Karolina ; Desai, Sameen. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0746-z.

Full description at Econpapers || Download paper

3
182020Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Bowling, Rich ; Popko, Leszek ; Barmaz, Yves ; Rolo, Donato ; Koneswarakantha, Bjorn ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3.

Full description at Econpapers || Download paper

3
192019Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC). (2019). Westbrook, Johanna I ; Raban, Magdalena Z ; Mumford, Virginia ; Baysari, Melissa T ; Gates, Peter J. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:8:d:10.1007_s40264-019-00823-4.

Full description at Econpapers || Download paper

2
202019Correction to: A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding. (2019). Frauman, Albert ; Aminian, Parnaz ; Keith, Claire ; Liew, David ; McMaster, Christopher. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-019-00820-7.

Full description at Econpapers || Download paper

2
212020Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports. (2020). Grundmark, Birgitta ; Vidlin, Sara Hedfors ; Watson, Sarah ; Zekarias, Alem. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:12:d:10.1007_s40264-020-01000-8.

Full description at Econpapers || Download paper

2
222021Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project. (2021). Huerta, Consuelo ; Gini, Rosa ; Kahlert, Johnny ; Emborg, Hanne-Dorthe ; Titievsky, Lina ; Picelli, Gino ; Weibel, Daniel ; van der Aa, Lieke ; Villa, Marco ; Dodd, Caitlin ; Roberto, Giuseppe ; Willame, Corinne ; Lusignan, Simon ; McGee, Chris ; Martin-Merino, Elisa. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01031-1.

Full description at Econpapers || Download The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products. (2018). Morrato, Elaine H ; Freeman, Emily ; Frise, Sarah ; PEter, ; Bahri, Priya ; Russell, Andrea ; Smith, Meredith Y. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:4:d:10.1007_s40264-017-0619-x.

Full description at Econpapers || Download paper

2
242016Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Thomas, Michele ; Burstein, Phil J ; Powell, Gregory E ; Brownstein, John S ; Painter, Jeffery L ; Dasgupta, Nabarun ; Rodriguez, Harold W ; Pierce, Carrie E ; Bell, Heidi G ; Menius, Alan J ; Freifeld, Clark C ; Blowers, James ; Reblin, Tjark ; Seifert, Harry A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6.

Full description at Econpapers || Download paper<

2
252019Patient Registries: An Underused Resource for Medicines Evaluation. (2019). PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel Nogueras ; Castillon, Mireia ; Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00848-9.

Full description at Econpapers || Download paper

2
262017Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Fransson, Jonas ; Noren, Niklas G ; Chandler, Rebecca E ; Juhlin, Kristina ; Edwards, Ralph I ; Caster, Ola. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3.

Full description at Econpapers || Download paper

2
272018Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. (2018). Vroman, Benoit ; Tcherny-Lessenot, Stephanie ; Noren, Niklas G ; Maskell, Simon ; Lerch, Magnus ; Kurzinger, Marie-Laure ; Dietrich, Juergen ; Caster, Ola ; Stekelenborg, John ; Wisniewski, Antoni. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0699-2.

Full description at Econpapers || Download Drug-Induced Liver Injury: Highlights of the Recent Literature. (2019). Lewis, James H ; Rosenberg, Jessica ; Higley, Cory ; Barnhill, Michele S ; Real, Mark. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-0743-2.

Full description at Econpapers || Download paper

2
292018Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient’s Quality of Life: A Single-Center, 10-Year Experience from Southern Italy. (2018). Marciano, Antonia ; Sultana, Janet ; Giorgianni, Francesco ; lo Presti, Loredana ; Peditto, Matteo ; Trifiro, Gianluca ; Oteri, Giacomo. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:1:d:10.1007_s40264-017-0582-6.

Full description at Econpapers || Download paper

2
302018Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab. (2018). Gonzalez-Hernandez, Graciela ; Oconnor, Karen ; Loke, Yoon ; Sarker, Abeed ; Golder, SU ; Smith, Karen. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0707-6.

Full description at Econpapers || Download paper

2
312016Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study. (2016). Montastruc, Franois ; Rousseau, Vanessa ; Bondon-Guitton, Emmanuelle ; Mege, Mathilde ; Jacquot, Julien ; Durrieu, Genevieve. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0463-4.

Full description at Econpapers || Download paper

2
322019Detecting Adverse Drug Events with Rapidly Trained Classification Models. (2019). Patterson, Olga V ; Duvall, Scott L ; Alba, Patrick R ; Peterson, Kelly S ; Chapman, Alec B. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0763-y.

Full description at Econpapers || Download paper

2
332017Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences. (2017). Andri, Adriana ; Ipi, Ivana ; Montero, Dolores ; Coleman, Anna Marie ; Baldelli, Ilaria ; Cupelli, Amelia ; PEter, ; Vries, Sieta T ; Denig, Petra ; Ahlqvist-Rastad, Jane ; Wennberg, Annika . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0535-0.

Full description at Econpapers || Download paper

2
342017Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals. (2017). Bereznicki, Luke R ; Connolly, Michael ; Peterson, Gregory M ; Curtain, Colin ; Chalmers, Leanne ; Nair, Nibu Parameswaran . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0528-z.

Full description at Econpapers || Download paper

2
352020Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania. (2020). Guantai, Anastasia ; Oluka, Margaret ; Kamuhabwa, Appolinary ; Makonnen, Eyasu ; Bienvenu, Emile ; Minzi, Omary ; Olsson, Sten ; Aklillu, Eleni ; Barry, Abbie ; Gurumurthy, Parthasarathi ; Puijenbroek, Eugene ; Bergman, Ulf. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:4:d:10.1007_s40264-019-00898-z.

Full description at Econpapers || Download Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Yu, Hong ; Liu, Weisong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z.

Full description at Econpapers || Download paper

2
372019Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. (2019). Pirmohamed, Munir ; Gama, Sara ; Noren, Niklas G ; Dietrich, Juergen ; Tregunno, Phil ; Dasgupta, Nabarun ; Caster, Ola ; Antoni, ; Bergvall, Tomas ; Ptaszyska-Neophytou, Alicia ; Maskell, Simon ; Powell, Gregory ; Ellenius, Johan ; Pierce, Carrie E ; Stekelenborg, John ; Brosch, Sabine ; Newbould, Victoria ; Lewis, David. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00858-7.

Full description at Econpapers || Download Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

2
392020Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting. (2020). Wakao, Rika ; Noren, Niklas G ; Taavola, Henric ; Chandler, Rebecca E ; Kimura, Ryota ; Kubota, Yuki ; Fujiyoshi, YU ; Iwasa, Eiko. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:11:d:10.1007_s40264-020-00968-7.

Full description at Econpapers || Download paper

2
402018Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Moore, Nicholas ; Blin, Patrick ; Droz, Cecile ; Lassalle, Regis ; Abouelfath, Abdelilah ; Duong, Mai. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7.

Full description at Econpapers || Download paper

2
412018Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases. (2018). Bate, Andrew ; Hauben, Manfred ; Whalen, ED. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0640-8.

Full description at Econpapers || Download paper

2
422017Causality Assessment in Pharmacovigilance: Still a Challenge. (2017). Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0509-2.

Full description at Econpapers || Download paper

2
432019A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding. (2019). Frauman, Albert ; Aminian, Parnaz ; Keith, Claire ; Liew, David ; McMaster, Christopher. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-018-00794-y.

Full description at Econpapers || Download paper

2
442019Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem. (2019). Avorn, Jerry ; Zhou, Esther H ; Lappin, Brian M ; Rausch, Paula ; Schneeweiss, Sebastian ; Campbell, Eric G ; Sinha, Michael S ; Kesselheim, Aaron S ; Dal, Gerald J. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00849-8.

Full description at Econpapers || Download paper

2
452016The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Smith, Meredith Y ; Benattia, Isma . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9.

Full description at Econpapers || Download paper

2
462014Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave ; LePendu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David ; Callahan, Alison ; Low, Yen . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790.

Full description at Econpapers || Download paper

2
472019MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes. (2019). Wu, Yonghui ; Hogan, William R ; Gong, Yan ; Bian, Jiang ; Yang, XI. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0761-0.

Full description at Econpapers || Download paper

2
482018Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study. (2018). Rahman, Mirza ; Heumen, Emiel ; Peters-Strickland, Timothy ; Geis, Uli ; Coppin-Renz, Antonia ; Al-Dakkak, Imad ; Landsberg, Wally. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:8:d:10.1007_s40264-018-0662-2.

Full description at Econpapers || Download paper

2
492017Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention. (2017). Zeldis, Jerome B ; Sheehan, Paul ; Houn, Florence ; Freeman, John ; Bwire, Robert ; Brandenburg, Nancy A. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0501-2.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 22
YearTitle
2021Risk Management for the 21st Century: Current Status and Future Needs. (2021). Smith, Meredith Y ; Han, Soon Young ; Raine, June ; Moride, Yola ; Auth, Doris ; Mouchantaf, Rania. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:4:d:10.1007_s40264-020-01033-z.

Full description at Econpapers || Download paper

2021Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event. (2021). Gerbes, Alexander L ; Neumann, Jens ; Benesic, Andreas ; Weber, Sabine. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:6:d:10.1007_s40264-021-01049-z.

Full description at Econpapers || Download paper

2021Artificial Intelligence, Real-World Automation and the Safety of Medicines. (2021). Hobbiger, Steve F ; Bate, Andrew. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:2:d:10.1007_s40264-020-01001-7.

Full description at Econpapers || Download paper

2021Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices. (2021). Taylor, Robert ; Leonard, Eileen ; Cherry, Mark ; Mishalov, Ellen ; Savage, Elizabeth ; Dobracki, Pawel ; Kjoersvik, Oeystein ; Huysentruyt, Kristof ; Abatemarco, Danielle ; Patel, Bhavin. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01030-2.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Metformin doses to ensure efficacy and safety in patients with reduced kidney function. (2021). Daniel, ; John , ; Putt, Tracey L ; Walker, Robert J ; Cosgrove, Samuel ; Leishman, Jed C ; Wilson, Luke C. In: PLOS ONE. RePEc:plo:pone00:0246247.

Full description at Econpapers || Download paper

2021Generating Relevant Information from Patients in the Technology-Enhanced Era of Patient-Focused Drug Development: Opportunities and Challenges. (2021). Reaney, Matthew ; Posey, Michael ; Wilson, James C ; Cline, Jennifer. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:1:d:10.1007_s40271-020-00455-2.

Full description at Econpapers || Download paper

2021Patient Global Impression of Benefit–Risk (PGI-BR): Incorporating Patients’ Views of Clinical Benefit–Risk into Assessment of New Medicines. (2021). Hermann, Richard ; Paty, Jean ; Venerus, Meredith ; Meyers, Oren ; Blowfield, Matthew ; Flood, Emuella ; Halling, Katarina ; Eek, Daniel. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:10:d:10.1007_s40264-021-01079-7.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Follow-up on the Use of Advanced Analytics for Clinical Quality Assurance: Bootstrap Resampling to Enhance Detection of Adverse Event Under-Reporting. (2021). Rolo, Donato ; Menard, Timothe ; Barmaz, Yves ; Koneswarakantha, Bjorn. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:1:d:10.1007_s40264-020-01011-5.

Full description at Econpapers || Download paper

2021Bayesian Modeling for the Detection of Adverse Events Underreporting in Clinical Trials. (2021). Menard, Timothe ; Barmaz, Yves. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:9:d:10.1007_s40264-021-01094-8.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Microbiota Management for Effective Disease Suppression: A Systematic Comparison between Soil and Mammals Gut. (2021). Abd-Elgawad, Ahmed M ; Idbella, Mohamed ; Bonanomi, Giuliano. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:14:p:7608-:d:590195.

Full description at Econpapers || Download paper

2021Authors’ Reply to Robert P. Giugliano and Colleagues’ Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”. (2021). Poluzzi, Elisabetta ; Diemberger, Igor ; Fusaroli, Michele ; Raschi, Emanuel. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:4:d:10.1007_s40264-021-01054-2.

Full description at Econpapers || Download paper

2021An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. (2021). Stegmann, Jens-Ulrich ; Herve, Caroline ; Lecrenier, Nicolas ; Co, Maribel ; Tavares-Da, Fernanda ; Pirrotta, Paola. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:12:d:10.1007_s40264-021-01118-3.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020. (2021). Grundmark, Birgitta ; Vidlin, Sara Hedfors ; Savage, Ruth ; Gauffin, Oskar ; Rocca, Elena. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:9:d:10.1007_s40264-021-01091-x.

Full description at Econpapers || Download paper

2021Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19. (2021). Sendi, Parham ; Battegay, Manuel ; Stoeckle, Marcel ; Leuppi-Taegtmeyer, Anne ; Stader, Felix ; Marzolini, Catia. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:2:d:10.1007_s40264-020-01025-z.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Patient Organizations’ Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation. (2021). Hunsel, Florence ; Hall, Victoria ; Matos, Cristiano ; Chinchilla, Katherine. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:2:d:10.1007_s40264-020-00999-0.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2021

YearCiting document
2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021The Effectiveness and Value of Written Medicine Information Across Asia and Africa: Systematic Review. (2021). Krska, Janet ; Corlett, Sarah A ; Nualdaisri, Pitchaya. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:12:d:10.1007_s40264-021-01114-7.

Full description at Econpapers || Download paper

2021Authors’ Reply to Michael Auerbach’s Comment on: “Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using. (2021). Numan, Syed ; Kaluza, Karolina ; Trumbo, Henry ; Goodnough, Lawrence T. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:5:d:10.1007_s40264-021-01059-x.

Full description at Econpapers || Download paper

2021The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan. (2021). Zhang, Ying ; Song, Yanna ; Harigai, Masayoshi ; Sasaki, Nobuhito ; Khan, Nasser ; Kameda, Hideto ; Tanaka, Yoshiya ; Yamaoka, Kunihiro ; Takeuchi, Tsutomu. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:6:d:10.1007_s40264-021-01067-x.

Full description at Econpapers || Download paper

2021A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs. (2021). Manzo, Claudia ; Lacivita, Cynthia ; Toyserkani, Gita A ; Kesselheim, Aaron S ; Woloshin, Steven ; Chin, Kristyn ; Avorn, Jerry ; Feldman, William B ; Bykov, Katsiaryna ; Huybrechts, Krista F ; Mitra-Majumdar, Mayookha ; Gagne, Joshua J ; Sarpatwari, Ameet ; Dal, Gerald J ; Pinnow, Ellen ; Zhou, Esther H. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:7:d:10.1007_s40264-021-01070-2.

Full description at Econpapers || Download Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders. (2021). , Peter ; PEter, ; Hoes, Arno W ; McGettigan, Patricia ; Berg, Marijke H ; Vries, Sieta T ; Jonker, Carla J. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:8:d:10.1007_s40264-021-01081-z.

Full description at Econpapers || Download paper

2021Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessme. (2021). , Sabine ; Dogne, Jean-Michel ; Inoubli, Adrien ; Morales, Daniel R ; Bahri, Priya. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:9:d:10.1007_s40264-021-01096-6.

Full description at Econpapers || Download paper

Recent citations received in 2020

YearCiting document
2020Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand. (2020). Harrison-Woolrych, Mira ; Vohra, Sunita ; Harmark, Linda ; Dong, Christine Yang ; Sheridan, Jane L ; Barnes, Joanne. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:10:d:10.1007_s40264-020-00963-y.

Full description at Econpapers || Download paper

2020Real-World Data on Bleeding Risk and Anticoagulation in Patients with IPF Treated with Antifibrotics. (2020). Kalluri, Meena ; Bendstrup, Elisabeth. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:10:d:10.1007_s40264-020-00991-8.

Full description at Econpapers || Download paper

2020Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines. (2020). Praet, Nicolas ; Begaud, Bernard ; Nachbaur, Gaelle ; Bauchau, Vincent ; Salvo, Francesco ; Bollaerts, Kaatje ; Arlegui, Hugo. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:11:d:10.1007_s40264-020-00984-7.

Full description at Econpapers || Download paper

2020Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance. (2020). Poluzzi, Elisabetta ; Diemberger, Igor ; Fusaroli, Michele ; Raschi, Emanuel. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:11:d:10.1007_s40264-020-00990-9.

Full description at Econpapers || Download paper

2020Liver Injury Associated with the Selective Progesterone Modulator Ulipristal. (2020). Bjornsson, Einar S. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:12:d:10.1007_s40264-020-01004-4.

Full description at Econpapers || Download paper

2020An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System. (2020). Muoz, Monica A ; Dal, Gerald J ; Kortepeter, Cindy M ; Jones, Christopher S ; Marwitz, Kathryn. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:5:d:10.1007_s40264-020-00908-5.

Full description at Econpapers || Download paper

2020A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study. (2020). Toutain, Pierre-Louis ; Montastruc, Jean-Louis. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:7:d:10.1007_s40264-020-00955-y.

Full description at Econpapers || Download paper

2020Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment. (2020). Shakir, Saad ; Roy, Debabrata ; Dhanda, Sandeep ; Denyer, Jacqueline ; Evans, Alison ; Lane, Samantha ; Davies, Miranda ; Osborne, Vicki. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:8:d:10.1007_s40264-020-00966-9.

Full description at Econpapers || Download paper

2020Thromboembolism and Janus Kinase Inhibitors. (2020). Scott, David L ; Ibrahim, Fowzia. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:9:d:10.1007_s40264-020-00973-w.

Full description at Econpapers || Download paper

2020The Evolving Field of Risk Communication. (2020). Besley, John ; McComas, Katherine ; Balogway, Dominic. In: Risk Analysis. RePEc:wly:riskan:v:40:y:2020:i:s1:p:2240-2262.

Full description at Econpapers || Download paper

Recent citations received in 2019

YearCiting document
2019The Impact of Litigation-Associated Reports on Signal Identification in the US FDA’s Adverse Event Reporting System. (2019). Dal, Gerald J ; Muoz, Monica A. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:10:d:10.1007_s40264-019-00834-1.

Full description at Econpapers || Download paper

2019Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study. (2019). Harding, Abenah ; Andrews, Elizabeth B ; Garcia-Rodriguez, Luis ; Ziemiecki, Ryan ; Schink, Tania ; Robert, ; Ruigomez, Ana ; Cantero, Oscar F ; Plana, Estel ; Cainzos-Achirica, Miguel ; Odsbu, Ingvild ; Fortuny, Joan ; MacDonald, Thomas M ; Gilsenan, Alicia ; Linner, Love ; Karlsson, Par ; Kollhorst, Bianca. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:10:d:10.1007_s40264-019-00835-0.

Full description at Econpapers || Download Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. (2019). Kollhorst, Bianca ; Garcia-Rodriguez, Luis ; Andrews, Elizabeth B ; Robert, ; Ziemiecki, Ryan ; Cantero, Oscar F ; Schink, Tania ; Cainzos-Achirica, Miguel ; Ruigomez, Ana ; Gilsenan, Alicia ; Plana, Estel ; Fortuny, Joan ; MacDonald, Thomas M ; Linner, Love ; Karlsson, Par. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:10:d:10.1007_s40264-019-00836-z.

Full description at Econpapers || Download Comment on: “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments”. (2019). Jandhyala, Ravi. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00862-x.

Full description at Econpapers || Download paper

2019Authors’ Reply to Ravi Jandhyala’s Comment on “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Asse. (2019). PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel ; Castillon, Mireia ; Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00863-w.

Full description at Econpapers || Download Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews. (2019). de Ponti, Fabrizio ; Squizzato, Alessandro ; Gatti, Milo ; Bianchin, Matteo ; Raschi, Emanuel. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00866-7.

Full description at Econpapers || Download paper

2019Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Yu, Hong ; Liu, Weisong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z.

Full description at Econpapers || Download paper

2019Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records. (2019). Yu, Hong ; Jagannatha, Abhyuday ; Liu, Feifan. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0766-8.

Full description at Econpapers || Download paper

2019Safety of Novel Targeted Therapies in Oncology. (2019). Curigliano, Giuseppe ; Shah, Rashmi R. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:2:d:10.1007_s40264-018-0770-z.

Full description at Econpapers || Download paper

2019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Vries, Sieta T ; Antoni, ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download Building an Evidence Base on the Place of Industry-Sponsored Programs in Drug Safety Surveillance. (2019). Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-00791-1.

Full description at Econpapers || Download paper

2019From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data. (2019). Koutkias, Vassilis. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-00793-z.

Full description at Econpapers || Download paper

2019Authors’ reply to Schaffalitzky de Muckadell and colleague’s Comment on “Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isom. (2019). Wohlfeil, Stefan ; Toussi, Massoud ; Bocuk, Derya ; Gohlke, Annegret ; Nathell, Lennart ; Ehlken, Birgit. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-019-00815-4.

Full description at Econpapers || Download paper

2019Frailty and Drug Safety at Older Ages. (2019). Gulliford, Martin . In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-019-00796-4.

Full description at Econpapers || Download paper

2019Inflammation, Monoclonal Antibodies and Depression: Joining the Dots. (2019). Hunt, David. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:7:d:10.1007_s40264-019-00819-0.

Full description at Econpapers || Download paper

2019A Profile of Adverse Drug Reactions of Atazanavir- and Lopinavir-Based Antiretroviral Regimens in Namibia. (2019). Rennie, Timothy William ; Adenuga, Babafunso Aderemi. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:7:d:10.1007_s40264-019-00832-3.

Full description at Econpapers || Download paper

Recent citations received in 2018

YearCiting document
2018Comment on “Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence”. (2018). Akerman, Sarah ; Sullivan, Maria ; Fratantonio, James ; Silveira, Alexandra ; Marcopul, Kimberley ; Jain, Priya ; Bloomgren, Gary ; Silverman, Bernard . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0691-x.

Full description at Econpapers || Download paper

2018Authors’ Response to Silverman and Colleagues’ Comment on “Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence”. (2018). Wolfe, Daniel ; Saucier, Roxanne ; Dasgupta, Nabarun. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0692-9.

Full description at Econpapers || Download paper

2018Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. (2018). Glanz, Jason M ; Binswanger, Ingrid A. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0705-8.

Full description at Econpapers || Download paper

2018Reply to Ward and Colleagues’ Comment on “Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors”. (2018). Lancaster, William J ; Ekstrom, Leeland ; Bernard, Gordon ; Bastarache, Lisa A ; Shirey-Rice, Jana K ; Roden, Dan M ; Pulley, Jill M ; Jerome, Rebecca N ; Denny, Joshua C. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0701-z.

Full description at Econpapers || Download paper

2018Ibuprofen and Paracetamol: Acceptably Safe for All?. (2018). MacDonald, Thomas M ; MacKenzie, Isla ; Pigazzani, Filippo. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0717-4.

Full description at Econpapers || Download paper

2018Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action. (2018). Straus, Sabine ; Lesicar, Marina ; Giusti, Marina Dimov ; Sarinic, Viola Macolic ; de Ferraz, Margarida Viana ; Foy, Mick ; Loughlin, Louise ; Raine, June ; Radecka, Anna ; Ivanovic, Jelena ; Pallos, Julia ; Montero, Dolores . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0708-5.

Full description at Econpapers || Download paper

2018Authors’ Response to Braillon’s Comment on: “Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring”. (2018). Ruhe, Henricus ; Bakker, Roberto ; Roon, Eric ; Mulder, Hans ; Seldenrijk, Adrie ; Simoons, Mirjam. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0716-5.

Full description at Econpapers || Download paper

2018Comment on: “Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs”. (2018). zhao, liang ; Swain, Richard S ; Mosholder, Andrew D ; Levin, Robert L ; Suggs, Courtney M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0726-3.

Full description at Econpapers || Download paper

2018Authors Reply to Courtney Suggs and Colleagues’ Comment on: “Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs”. (2018). Berg, Richard L ; Peissig, Peggy L ; Qian, Jingjing ; Alatawi, Yasser ; Motiur, MD ; Cheng, Ning ; Hansen, Richard A ; Page, David C. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0728-1.

Full description at Econpapers || Download paper

2018Comment on “Central Demyelinating Diseases After Vaccination Against Hepatitis B Virus: A Disproportionality Analysis Within the VAERS Database”. (2018). Khromava, Alena ; Houdeau, Annick ; Cohen, Carine. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0733-4.

Full description at Econpapers || Download paper

2018Authors’ Reply to Katsuhiro Toda’s Comment on “Proton Pump Inhibitor Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case-Control Analysis”. (2018). Meier, Christoph R ; Jick, Susan S ; Bodmer, Michael ; Imfeld, Patrick. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0741-4.

Full description at Econpapers || Download paper

2018Comment on “Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project”. (2018). Louet, Agnes Lillo-Le ; Bellet, Florelle ; Audeh, Bissan ; Bousquet, Cedric. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0747-y.

Full description at Econpapers || Download paper

2018Authors’ reply: Safety of Human Papillomavirus Vaccines. (2018). Brotherton, Julia ; Pillsbury, Alexis ; Patel, Cyra ; Phillips, Anastasia ; MacArtney, Kristine. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:5:d:10.1007_s40264-018-0655-1.

Full description at Econpapers || Download paper

2018Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population”. (2018). Kawada, Tomoyuki. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0670-2.

Full description at Econpapers || Download paper

2018Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commer. (2018). Sclar, David A ; Fairman, Kathleen A ; Peckham, Alyssa M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0671-1.

Full description at Econpapers || Download paper

2018Active Safety Surveillance in Africa: Pragmatism and Agility. (2018). , Alexander ; Alexander, . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:8:d:10.1007_s40264-018-0677-8.

Full description at Econpapers || Download paper

2018Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis. (2018). Pariente, Antoine ; Neumann, Anke ; Weill, Alain ; Coste, Joel ; Billionnet, Cecile ; Maura, Geric. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:9:d:10.1007_s40264-018-0668-9.

Full description at Econpapers || Download paper